Literature DB >> 11966771

Expression of T cell receptor variable region families by bone marrow gammadelta T cells in patients with IgA nephropathy.

K S Buck1, E M Foster, D Watson, J Barratt, I Z A Pawluczyk, J F Knight, J Feehally, A C Allen.   

Abstract

IgA nephropathy (IgAN) is characterized by mesangial deposition of polymeric IgA (pIgA). Abnormalities of the IgA system include reduced mucosal and increased bone marrow (BM) pIgA production. Gammadelta T cells are regulators of mucosal IgA production and oral tolerance. We have described previously a deficiency of gammadelta T cells expressing Vgamma3 and Vdelta3 from the duodenal mucosa in IgAN. Since pIgA production is displaced to the BM, we have now studied BM gammadelta T cells in IgAN. Peripheral blood and BM aspirates were obtained from 14 patients with IgAN and 15 controls. Expression of TCR gamma and delta V region families was analysed by semiquantitative RT-PCR, and CDR3 spectratyping of Vgamma1-4 and Vdelta3 genes was performed. We found no difference between IgAN and controls in the V region usage of blood gammadelta T cells. However, in the BM of patients with IgAN, there was significantly reduced expression of the V region families Vgamma3 and Vdelta3, with the decrease in Vdelta3 being particularly striking. CDR3 spectratyping showed no abnormalities in blood or BM samples. Vgamma3 and Vdelta3 are underexpressed in the duodenum and the BM in IgAN. The combination of imbalanced mucosal and systemic pIgA production with deficient expression of gammadelta T cells using Vgamma3 and Vdelta3 in both sites may imply a role for these gammadelta T cells in the normal regulation of IgA immune responses, and in the complex immunopathogenesis of IgAN.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11966771      PMCID: PMC1906314          DOI: 10.1111/j.1365-2249.2002.01784.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Expression of the mucosal gamma delta T cell receptor V region repertoire in patients with IgA nephropathy.

Authors:  C Olive; A C Allen; S J Harper; A C Wicks; J Feehally; M C Falk
Journal:  Kidney Int       Date:  1997-10       Impact factor: 10.612

2.  Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA.

Authors:  S J Harper; A C Allen; J H Pringle; J Feehally
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

3.  Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy.

Authors:  J Barratt; E M Bailey; K S Buck; J Mailley; P Moayyedi; J Feehally; J H Turney; J E Crabtree; A C Allen
Journal:  Am J Kidney Dis       Date:  1999-06       Impact factor: 8.860

4.  Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization.

Authors:  L Gesualdo; M E Lamm; S N Emancipator
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

5.  gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses.

Authors:  K Fujihashi; J R McGhee; M N Kweon; M D Cooper; S Tonegawa; I Takahashi; T Hiroi; J Mestecky; H Kiyono
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

6.  Analysis of gamma delta V region usage in normal and diseased human intestinal biopsies and peripheral blood by polymerase chain reaction (PCR) and flow cytometry.

Authors:  A Bucht; K Söderström; S Esin; J Grunewald; S Hagelberg; I Magnusson; H Wigzell; A Grönberg; R Kiessling
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

7.  Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA.

Authors:  S J Harper; A C Allen; M C Béné; J H Pringle; G Faure; I Lauder; J Feehally
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

8.  Variable gene usage of T cell receptor gamma- and delta-chain transcripts expressed in synovia and peripheral blood of patients with rheumatoid arthritis.

Authors:  C Olive; P A Gatenby; S W Serjeantson
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

9.  Increase of both circulating Th1 and Th2 T lymphocyte subsets in IgA nephropathy.

Authors:  K N Lai; R T Ho; C K Lai; C H Chan; P K Li
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

10.  Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.

Authors:  A W van den Wall Bake; W E Beyer; J H Evers-Schouten; J Hermans; M R Daha; N Masurel; L A van Es
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

View more
  6 in total

1.  For further investigations in IgA nephropathy the approach from phenotype to genotype is welcome.

Authors:  F P Schena
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

Review 2.  Unconventional T cells and kidney disease.

Authors:  Hannah Kaminski; Lionel Couzi; Matthias Eberl
Journal:  Nat Rev Nephrol       Date:  2021-08-26       Impact factor: 28.314

Review 3.  Genetics and immunopathogenesis of IgA nephropathy.

Authors:  Hsin-Hui Yu; Kuan-Hua Chu; Yao-Hsu Yang; Jyh-Hong Lee; Li-Chieh Wang; Yu-Tsan Lin; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 10.817

4.  Regulatory effect of astragalus polysaccharides on intestinal intraepithelial γδT cells of tumor bearing mice.

Authors:  Shuyu Sun; Kang Zheng; Hongyan Zhao; Cheng Lu; Biao Liu; Changyuan Yu; Ge Zhang; Zhaoxiang Bian; Aiping Lu; Xiaojuan He
Journal:  Molecules       Date:  2014-09-23       Impact factor: 4.411

Review 5.  Human gamma delta T cells: candidates for the development of immunotherapeutic strategies.

Authors:  Susann Beetz; Lothar Marischen; Dieter Kabelitz; Daniela Wesch
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

Review 6.  Tuberculosis-associated IgA nephropathy.

Authors:  Yamei Wang; Yuhong Tao
Journal:  J Int Med Res       Date:  2018-06-04       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.